+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 20Years - 65Years
All Genders
ID07388407

Study of Genetic Factors Affecting Leflunomide Treatment in Pakistani Adults with Rheumatoid Arthritis

Led by Foundation University Islamabad · Updated on 2026-02-05

110

Participants Needed

2

Research Sites

13 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to study the pharmacogenetics of leflunomide in treating rheumatoid arthritis RA among Pakistani patients. RA is an autoimmune disease causing inflammation, and leflunomide is a second-line drug used when first-line treatments fail. The study plans to explore the relationship between genetic variations in the DHODH and ABCG2 genes and the drugs effectiveness and side effects. This could help tailor treatment to individual patients based on their genetics. Participants taking leflunomide as their only disease-modifying anti-rheumatic drug DMARD will be enrolled. Blood samples will be collected to extract DNA and identify genetic markers called single nucleotide polymorphisms SNPs. Patients will be followed for six months with visits three months apart to evaluate disease activity using the DAS28 score, ultrasonography, and various blood tests including liver function, ESR, CRP, and anti-CCP antibodies. The study will analyze how these genetic markers relate to treatment results and side effects. During the study, participants will have clinical assessments at baseline, three months, and six months, including monitoring for side effects such as nausea, liver toxicity, and infections. Researchers will collect detailed data on symptoms, laboratory tests, and imaging results. The main outcome is the change in disease activity score DAS28 over two years, along with identification of genetic factors affecting drug response and liver toxicity. This information aims to improve treatment decisions for RA patients in Pakistan.

CONDITIONS

Brief Title

Pharmacogenetics of Leflunomide in the Management of Rheumatoid Arthritis

Research Team

D

Dr. Zarafshan Bader, MPhil, MBBS

D

Dr Abida Shaheen, PHD, MBBS, FAIMER FELLOW

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here